43: An Interview With CureDuchenne Chief Scientific Officer Dr. Michael Kelly
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Michael Kelly, PhD, chief scientific officer at CureDuchenne, on the latest developments in exon skipping, gene therapy and other treatments for Duchenne muscular dystrophy.
You May Also Like

Meditative Prayers by Pray.com
iHeartPodcasts and Pray.com

I'm Quitting Alcohol
David Boyle - Comedian

Masculine Mindset | Affirmations for Men
Motivation

Sleep Reset
Motivation

Overthinking Rehab
Motivation

Gratitude Morning Affirmations
Motivation

Stress Free | Daily Affirmations
Motivation

Success Playbook
Motivation

Emotional Intelligence Playbook
Motivation

Speak with Power | Daily Confidence Boost
Motivation
Community discussion